| clinical and virological associations between external anogenital warts and cervical hpv infection in an std clinic population. | to determine the significance of overt anogenital warts as indicators of human papillomavirus (hpv) infection of the cervix, 177 women attending a sydney std clinic were screened for evidence of cervical hpv infection using clinical criteria together with cytology and hpv dna dot hybridization. hpv dna probing was also performed on biopsies of 50 exophytic warts. a very high prevalence of both anogenital warts (40%), and of cervical hpv infection (58%) was indicated in this group of women. in th ... | 1991 | 1645205 |
| high prevalence of human papillomavirus and cervical intraepithelial neoplasia in a young australian std population. | two hundred and forty-five women consecutively attending a large city sexually transmitted diseases (std) centre had routine cervical screening performed by both the pap smear and, in addition, a cervigram. the aim of this study was to determine the prevalence of hpv infection, cin and cervical cancer in an std population. the mean age of this group was 26 years with a range from 16 to 53 years. colposcopy and biopsy revealed a prevalence for human papillomavirus (hpv) of 41%, and 20.4% for cerv ... | 1991 | 1655057 |
| pills, partners and preventive prospects: in-situ cancer of the cervix. | australian women face a lifetime risk of dying of cervical cancer of 1 in 250. current epidemiological evidence suggests that the age at 1st sexual intercourse and the number of sexual partners are important risk factors for cervical carcinogenesis. other risk factors for invasive cervical cancer include cigarette smoking, deficiencies of dietary and plasma micronutrients, and oral contraceptive (oc) use. the recently documented increased risk of invasive cervical cancer associated with longt ... | 1989 | 2541323 |
| comparison of cytology and cervicography in screening a high risk australian population for cervical human papillomavirus and cervical intraepithelial neoplasia. | two different screening methods, the papanicolaou (pap) smear and cervigram were compared in screening 245 sydney women over a 6-month period in 1988 at a city sexually transmitted diseases (std) centre, for cervical human papillomavirus (hpv), cervical intraepithelial neoplasia (cin) and cervical cancer. the pap smear through the identification of cytologically abnormal cells correctly detected 54% of cases of histologically proven cin and 39.2% of cases of hpv. the cervigram through the identi ... | 1993 | 8216120 |
| the fitzroy valley pap smear register. cervical screening in a population of australian aboriginal women. | to describe the operation of the fitzroy valley pap smear register, a population-based call and recall system for cervical screening for aboriginal women, and the prevalence of cervical abnormalities in the women screened. | 1993 | 8450781 |
| the descriptive epidemiology of warts in the community. | warts are common skin infections caused by human papillomavirus (hpv) and affect most people sometime in their life. a number of epidemiological studies on the prevalence of warts have been completed in schools, various occupational groups, general practices and hospitals. all studies have relied on a subjective measure for the diagnosis of warts. cross-sectional studies completed in schools have shown the prevalence in children to vary from 2 to 20%. occupational handlers of meat, poultry and f ... | 1996 | 8687332 |
| cervical human papillomavirus infections in commercial sex workers-risk factors and behaviours. | we have investigated the prevalence of, and risk factors for, cervical human papillomavirus (hpv) infection in commercial sex workers (csws) and controls attending the same sexual health clinics in sydney. a self-administered 'risk factor' questionnaire was completed and a pap smear and a specimen for hpv detection and typing were taken. results from the 288 csws and 266 controls were assessed by univariate and multivariate analyses. no significant difference in the rates of cervical hpv infecti ... | 2003 | 14678594 |
| sexual health issues after lung transplantation: importance of cervical screening. | to determine the incidence and outcomes of human papillomavirus infection and cervical abnormalities after lung transplantation, we performed a retrospective cross-sectional study of all 166 female recipients who underwent transplantation between february 1989 and june 2001 at our institution. the incidence of low-grade epithelial abnormality of the cervix, cervical intra-epithelial neoplasia (cin) 1, and the earliest pre-cancerous changes of the cervical epithelial cells, cin 3, in the post-tra ... | 2004 | 15261186 |
| comparative analysis of characteristics of women with cervical cancer in high- versus low-incidence regions. | to identify particular characteristics that might help explain the markedly higher rate of invasive cervical cancer in southern china as compared with australia. | 2004 | 15350376 |
| australian women's needs and preferences for information about human papillomavirus in cervical screening. | the role of human papillomavirus (hpv) in cervical cancer and developments in medical technology to prevent cervical cancer has changed information needs for women participating in cervical screening. | 2005 | 16156944 |
| sexually transmitted infections, blood-borne viruses and risk behaviour in an australian senior high school population--the shlirp study. | to determine the feasibility and acceptability of screening for sexually transmitted infections and blood-borne viruses and to study the profile of sexual activity and other risk behaviours in a senior high school population. | 2005 | 16402670 |
| prevalence of genital human papillomavirus dna in a sample of senior school-aged women in the australian capital territory. | a strong association between persistent infection with oncogenic types of human papillomavirus (hpv) and cervical cancer is well established. small numbers of international studies examining adolescent hpv infection and the risk factors associated are published, but there is currently no evidence on the prevalence and risk factors for hpv in an australian, sexually active female adolescent population. | 2006 | 16800394 |
| knowledge and acceptance of human papillomavirus vaccination: perspectives of young australians living in melbourne, australia. | this paper explores knowledge of and attitudes toward sexually transmissible infections, human papillomavirus (hpv) vaccination and vaccine acceptability among young people in australia. it also explores factors influencing acceptance and attempts to identify gender differences in knowledge and acceptance. | 2006 | 16800395 |
| human papillomavirus prevalence in canberra high school students: significance for vaccination strategies and adolescent health. | | 2006 | 17112445 |
| vaccinating young adults against human papillomavirus: the importance of understanding health decision-making and behaviour. | vaccination of young teenage females against human papillomavirus (hpv) with a newly licenced quadrivalent vaccine designed to prevent cervical cancer and genital warts has recently been recommended by the australian government and will be implemented through schools from april 2007. in addition, a fully funded 'catch-up' vaccination program for young women up to age 26 years has been approved for a 2-year period, from july 2007. as general practitioners (gps) will be the main immunisation provi ... | 2007 | 17524291 |
| abnormal anal cytology in high-risk human papilloma virus infection in hiv-infected australians. | to assess the prevalence of abnormal anal cytology and high-risk human papilloma virus (hpv)-type infection in hiv-infected people with a cd4 cell count >300 cells/microl. | 2008 | 17881414 |
| challenges to accepting a human papilloma virus (hpv) vaccine: a qualitative study of australian women. | a vaccine that protects women against the two most frequent high-risk genotypes of human papilloma virus (hpv) and the two types that cause 90 percent of genital warts was licensed in june 2006 in the usa and australia. it is important to understand whether a vaccine delivered to young women before the onset of sexual activity would be acceptable. the goal of this project was to investigate the knowledge and awareness of victorian women about cervical cancer and hpv infections, and their beliefs ... | 2007 | 18019286 |
| estimates for cervical abnormalities in vanuatu. | to use the pap smear to establish a recent prevalence of cervical abnormalities within a select population in vanuatu, a developing country. | 2007 | 18081580 |
| squamous cell carcinomas in children and young adults: a new wave of a very rare tumor? | squamous cell carcinomas (sccs) seem to have become more common recently. this study aims to check whether the increase is real and to review possible etiologic factors and problems in diagnosis. | 2007 | 18082703 |
| comparison of a novel hpv test with the hybrid capture ii (hcii) and a reference pcr method shows high specificity and positive predictive value for 13 high-risk human papillomavirus infections. | it is well established that human papillomavirus (hpv) infection is highly related to the development of precursor lesions of cervical cancer and uterine cancers. however, for a pre-cancerous lesion to develop, a persistent infection with a high-risk type hpv is necessary. the digene hybrid capture ii (hcii) assay is the only fda approved method used in conjunction with cytology for hpv screening of women older than 30. the hcii has moderate sensitivity (64.7%) and is dependent on the cellular c ... | 2008 | 18262463 |
| [study on cervical intraepithelial neoplasia in relation to human papillomavirus and co-factors: a case-control study in china and australia]. | this study was to elucidate the role of human papillomavirus (hpv) types and cofactors in the development of cervical intraepithelial neoplasia (cin). | 2007 | 18399139 |
| high-grade cervical abnormalities and screening intervals in new south wales, australia. | this study aims to determine the association of two versus three year screening intervals with the likelihood of detection of a high-grade cervical abnormality and cervical cancer. | 2008 | 18416954 |
| hpv vaccine catch up schedule - an opportunity for chlamydia screening. | the human papillomavirus (hpv) vaccine (gardasil) catch up schedule in general practice is available until june 2009 to females not in school and under the age of 27 years. a course of three injections is given over 6 months. this provides a unique opportunity for sexual health screening in an age group where chlamydia screening is a priority. | 2008 | 18592070 |
| the predicted impact of vaccination on human papillomavirus infections in australia. | vaccines based on human papillomavirus (hpv) 16 and 18 virus-like particles have the potential to prevent approximately 70% of cervical cancers. in australia, public vaccination against hpv commenced in april 2007, and includes routine vaccination of females aged 12-13 years, and a 2-year school and gp-based catch-up in females aged 12-26 years. the objectives of this study were to estimate initial vaccination coverage rates, to describe current patterns of sexual behavior in young females, and ... | 2008 | 18636563 |
| effect of community consultation on recruitment of indigenous women to a human papillomavirus prevalence study. | | 2008 | 18707573 |
| anaphylaxis following quadrivalent human papillomavirus vaccination. | in 2007, australia implemented the national human papillomavirus (hpv) vaccination program, which provides quadrivalent hpv vaccine free to all women aged 12-26 years. following notification of 7 presumptive cases of anaphylaxis in the state of new south wales, australia, we verified cases and compared the incidence of anaphylaxis following hpv vaccination to other vaccines in comparable settings. | 2008 | 18762618 |
| human papillomavirus and cervical cancer in australasia and oceania: risk-factors, epidemiology and prevention. | the region encompassing australasia and oceania, including australia, new zealand, fiji and papua new guinea, is a diverse one with respect to ethnicities, cultures and behaviours. it includes countries with comprehensive cervical cytology screening programmes which can be credited with significant reductions in cervical cancer incidence and mortality, and countries with no prevention programmes and significantly higher incidence and mortality. as elsewhere in the world, human papillomavirus (hp ... | 2008 | 18945417 |
| "i want the one for older women" - extending the human papillomavirus vaccine population base. | | 2008 | 19051385 |
| more data from australia on sensitivity to hpv vaccine. | | 2009 | 19136536 |
| comparing knowledge and perceived risk related to the human papilloma virus among australian women of diverse sexual orientations. | the study compared levels of awareness of human papilloma virus (hpv) as a sexually transmissible infection (sti) between women of different sexual orientations. it also examined self-reported risk factors for hpv infection, perceived level of personal risk, and willingness to have the hpv vaccine. | 2009 | 19236366 |
| hpv vaccination catch up program - utilisation by young australian women. | the quadrivalent human papilloma virus (hpv) vaccine provides protection against hpv types 6 and 11, and 16 and 18. the australian government's offer of free vaccination to women aged 18-26 years of age through general practitioners ends 30 june 2009. | 2009 | 19283241 |
| anal human papillomavirus genotype diversity and co-infection in a community-based sample of homosexual men. | to determine the prevalence and risk factors for anal human papillomavirus (hpv) infection in community-based cohorts of homosexual men in sydney, australia. | 2009 | 19342375 |
| the health and economic impact of cervical cancer screening and human papillomavirus vaccination in kidney transplant recipients. | the risk of cervical cancer in women who are kidney transplant recipients is increased, but little is known about the effectiveness of screening and human papillomavirus (hpv) vaccination in this group of women. we sought to determine the cost effectiveness of annual screening for cervical cancers using conventional cytology, liquid-based cytology (lbc), and pretransplant hpv vaccination in kidney transplant recipients. | 2009 | 19352131 |
| interim estimates of human papillomavirus vaccination coverage in the school-based program in australia. | in november 2006, the australian government announced the national hpv vaccination program, consisting of a course of prophylactic human papillomavirus (hpv) vaccine for all australian females aged 12-26 years. females aged 12-18 years are vaccinated through school-based programs. the school-based component commenced in april 2007, with the school years targeted varying across jurisdictions. each jurisdiction maintains comprehensive records of hpv doses delivered in the school-based programs alt ... | 2008 | 19374275 |
| marrying research, clinical practice and cervical screening in australian aboriginal women in western new south wales, australia. | research shows that australian aboriginal women experience a significantly higher rate of mortality from cervical cancer than non-aboriginal women. we now understand that infection with human papillomavirus (hpv) is a necessary pre-requisite for cervical cancer. this knowledge, together with the development of prophylactic vaccines against the hpv types most commonly associated with cervical cancer (16 and 18), made it vital to gain nationally representative hpv genotyping data for australian wo ... | 2009 | 19459723 |
| hpv genotype prevalence in women with abnormal pap smears in melbourne, australia. | carcinoma of the cervix and its precursor, high-grade cervical intraepithelial neoplasia (cin2/3), are associated with persistent oncogenic human papillomavirus (hpv) infection, particularly hpv 16 and 18. hpv genotype distribution varies with severity of cervical disease, patient demographics such as age, as well as geographical location. in this study, hpv genotype prevalence was determined, using the roche linear array genotyping test, among a cohort of 1,676 women being managed with ablative ... | 2009 | 19475612 |
| the incidence of genital warts in australian women prior to the national vaccination program. | the quadrivalent human papillomavirus (hpv) vaccine currently being delivered to australian women aged 12-26 years under the national hpv vaccination program promises to substantially reduce the incidence of genital warts. we review what is known about the burden of genital warts among australian women. incidence appears to peak among women aged 20-24 years, of whom 1.4% report genital warts in the previous year and who are hospitalised for treatment at a rate of 26 per 100,000. a surveillance s ... | 2009 | 19653953 |
| human papillomavirus dna detected in peripheral blood samples from healthy australian male blood donors. | recent studies have shown that human papillomavirus (hpv) dna can be found in circulating blood, including peripheral blood mononuclear cells (pbmcs), sera, plasma, and arterial cord blood. in light of these findings, dna extracted from pbmcs from healthy blood donors were examined in order to determine how common hpv dna is in blood of healthy individuals. blood samples were collected from 180 healthy male blood donors (18-76 years old) through the australian red cross blood services. genomic d ... | 2009 | 19697401 |
| outcomes from a mass media campaign to promote cervical screening in nsw, australia. | despite the decline in the incidence of cervical cancer in australia as a result of population screening, a substantial proportion of women in nsw screen less regularly than the recommended two-yearly interval or do not screen. with higher rates of cervical cancer in unscreened and underscreened women, and despite the introduction of the human papillomavirus vaccine, there remains a need to continue to remind women to screen. the mass media has been shown to be effective at improving participati ... | 2010 | 19822553 |
| rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women. | this study aimed to determine if the australian human papillomavirus (hpv) vaccination programme has had a population impact on presentations of genital warts. | 2009 | 19837728 |
| genital warts incidence and healthcare resource utilisation in australia. | to estimate for the first time the incidence and healthcare resource utilisation associated with genital warts (gw) in australia prior to the human papillomavirus vaccination programme. | 2010 | 19965802 |
| a review of histological outcomes from peri-menopausal and post-menopausal women with a cytological report of possible high grade abnormality: an alternative management strategy for these women. | to investigate the histological outcomes of women with cytological reports of possible high grade abnormality and to determine if patient age may be a clinically significant factor in determining the presence of high grade disease for this cytological category. | 2010 | 20025476 |
| prevalence of other sexually transmissible infections in patients with newly diagnosed anogenital warts in a sexual health clinic. | anogenital warts are a common initial presentation to the canberra sexual health centre. it is anticipated that the introduction of human papillomavirus vaccination will reduce the incidence of anogenital warts. the present study determines the prevalence of other sexually transmissible infections in patients newly diagnosed with warts who may not have presented for screening without the impetus of a genital lump. | 2010 | 20152097 |
| abnormal pap tests after the hpv vaccine. | worldwide, cervical cancer affects 500 000 women and causes 275 000 deaths annually. persistent infection with one of 13 oncogenic types of human papillomavirus (hpv) is now known to be the cause of both squamous and adenocervical carcinomas of the cervix. the pap test involves the examination of exfoliated cells from the cervix and has been shown to be an effective way of detecting the precursors of squamous cell carcinoma. in australia, commencing in 2007, a free quadrivalent hpv vaccine was o ... | 2009 | 20369150 |
| human papillomavirus and cervical cancer: gardasil vaccination status and knowledge amongst a nationally representative sample of australian secondary school students. | the aim of this paper was to measure student knowledge of hpv and risks associated with cervical cancer, explore associated factors, correlate knowledge of hpv and cervical cancer with other domains of sexual health related knowledge and estimate student self-reported rates of hpv immunisation. data were from a nationally representative cross-sectional stratified cluster sample of year 10 and 12 students in the australian secondary school system. contingency table, comparison of means, correlati ... | 2010 | 20434543 |
| interventions for young people in australia to reduce hiv and sexually transmissible infections: a systematic review. | like young people in other developed countries, sexually active young australians can have an increased risk of acquiring sexually transmissible infections (stis). this paper reviews intervention programs that aim to reduce the incidence and transmission of hiv and stis among young people in australia. | 2010 | 20465974 |
| estimating the prevalence of and treatment patterns for juvenile onset recurrent respiratory papillomatosis in australia pre-vaccination: a pilot study. | recurrent respiratory papillomatosis (rrp) causes serious morbidity. rrp in australia may be eliminated in the near future following the implementation of a national vaccination program using a human papillomavirus (hpv) vaccine that protects against infection with hpv types 6 and 11, those responsible for rrp. baseline data on rrp prevalence and disease burden in australia are lacking. | 2010 | 20719212 |
| 'it's a logistical nightmare!' recommendations for optimising human papillomavirus school-based vaccination experience. | to date, no published studies examine procedural factors of the school-based human papillomavirus (hpv) vaccination program from the perspective of those involved. this study examines the factors that were perceived to impact optimal vaccination experience. | 2010 | 20719214 |
| national survey of general practitioners' experience of delivering the national human papillomavirus vaccination program. | between 2007 and 2009, australian general practitioners (gps) were involved in implementing a population-based human papillomavirus (hpv) vaccination program. we investigated gps' experiences of delivering the hpv vaccine to women aged 18-26. | 2010 | 20719217 |
| knowledge of human papillomavirus (hpv) and the hpv vaccine in a national sample of australian men and women. | human papillomavirus (hpv) knowledge has rarely been investigated in the context of a national vaccination program. the present study investigated hpv knowledge after the introduction of a national hpv vaccination program in australia using a national sample of men and women. | 2010 | 20719218 |
| monitoring the control of human papillomavirus (hpv) infection and related diseases in australia: towards a national hpv surveillance strategy. | this paper describes a possible multifaceted approach to human papillomavirus (hpv) related surveillance in australia following implementation of a national hpv vaccination program. we describe eight main components: monitoring of vaccine coverage, vaccine safety, type-specific hpv infection surveillance, cervical cytology (pap screening) coverage and screen detected lesion prevalence, cervical cancer incidence and mortality, genital wart incidence, incidence of recurrent respiratory papillomato ... | 2010 | 20719220 |
| human papillomavirus vaccine safety in australia: experience to date and issues for surveillance. | australia was one of the first countries to licence a quadrivalent human papillomavirus (hpv) vaccine, rapidly followed by a federally funded program of universal vaccination of a broad age group of females through schools (12 to 18 years) and primary care (19 to 26 years). as of august 2009, more than 5.8 million doses of gardasil((r)) (quadrivalent; merck, new jersey, usa) have been distributed in australia and a total of 1394 suspected adverse events following immunisation (aefi) have been re ... | 2010 | 20719221 |
| what can surveillance of genital warts tell us? | in this review, we describe the recent epidemiology of genital warts and postulate what the future may hold as a result of the introduction of the quadrivalent human papillomavirus (hpv) vaccine. hpv types 6 or 11 are responsible for most cases and they develop in about two-thirds of women a few months after hpv 6 or 11 infections are first detected by polymerase chain reaction. surveillance data, cohort studies and cross-sectional surveys suggest that the annual incidence of genital warts excee ... | 2010 | 20719222 |
| cytology and cervical cancer surveillance in an era of human papillomavirus vaccination. | cytological and cancer surveillance will provide the most effective indications of short-term effects and long-term outcomes of the introduction of the human papillomavirus (hpv) vaccine in australia. this article outlines how this surveillance is proposed to occur through the established national monitoring mechanisms of the national cervical screening program in the annual australian institute of health and welfare (aihw) publication 'cervical screening in australia'. cytological surveillance ... | 2010 | 20719223 |
| models of cervical screening in the era of human papillomavirus vaccination. | epidemiologic and economic evaluation using simulation modelling can support complex policy decisions, and is an important tool in predicting the future interaction between human papillomavirus vaccination and cervical screening. several categories of screening program evaluation are of interest, including: (1) changes to screening considered over the short term, over which the effects of vaccination should be confined to the youngest age groups (<30 years old); (2) the medium and long-term effe ... | 2010 | 20719228 |
| the attitudes of australian gynaecologists to hpv vaccination: an asccp survey. | with human papilloma virus (hpv) vaccines now approved for women up to 45 years of age, gynaecologists in australia will be approached increasingly for advice on whether to have the hpv vaccine. | 2010 | 21039383 |
| commentary on opinion pieces re australian human papillomavirus vaccine policy. | | 2010 | 21058498 |
| closing editorial: processes, opportunities and challenges after introduction of human papillomavirus vaccine. | | 2010 | 21058499 |
| quadrivalent human papillomavirus vaccination and trends in genital warts in australia: analysis of national sentinel surveillance data. | quadrivalent human papillomavirus (hpv) vaccine has high efficacy in clinical trials but no reports describe its effects at a population level. from july, 2007, australia was the first country to fund a vaccination programme for all women aged 12-26 years. we established a national surveillance network in australia and aimed to identify trends in diagnoses of genital warts in 2004-09. | 2010 | 21067976 |
| knowledge of cervical cancer, pap testing and the human papillomavirus among young australian women. | in 2007, the australian federal government implemented an ongoing national human papillomavirus immunisation program for females aged 12 to 13 years. those aged up to 26 years were able to receive the vaccine free of charge from their general practitioner until june 2009. the purpose of this study was to determine the level of participation in the national human papillomavirus vaccination and cervical cancer screening programs and knowledge of cervical cancer, pap testing and the human papilloma ... | 2010 | 21118067 |
| prevalence of and risk factors for human papillomavirus (hpv) infection among hiv-seronegative men who have sex with men. | we examined the baseline prevalence of penile, scrotal, perineal/perianal, and intra-anal human papillomavirus (hpv) infection in human immunodeficiency virus (hiv)-seronegative men who have sex with men (msm). | 2011 | 21148498 |
| hpv vaccine promotion: does referring to both cervical cancer and genital warts affect intended and actual vaccination behavior? | young women have poor awareness that human papillomavirus (hpv) can cause both cervical cancer and genital warts, a sexually transmitted infection (sti). a newly developed hpv vaccine can provide protection against both cervical cancer and genital warts. this vaccine could be promoted by health authorities/professionals as preventing cervical cancer plus genital warts, or cervical cancer alone. because stigma around stis may reduce acceptance of the vaccine, the effect of information framing ('c ... | 2011 | 21185992 |
| nsw annual immunisation coverage report, 2009. | this is the first in a series of annual immunisation coverage reports that document trends in nsw for a range of standard measures derived from australian childhood immunisation register data, including overall coverage at standard age milestones and for individual vaccines. this report includes data up to and including 2009. | 2010 | 21211474 |
| the domino effect: adolescent girls' response to human papillomavirus vaccination. | to examine the experience of fear, the fear response, and factors affecting fear in adolescents undergoing school-based human papillomavirus (hpv) vaccination. | 2011 | 21426284 |
| vaccines--but not as we know them: an ethical evaluation of hpv vaccination policy in australia. | to show how systematic ethical evaluation of public health policy may reveal issues of moral significance for critical examination. | 2011 | 21463416 |
| the association between cutaneous squamous cell carcinoma and betapapillomavirus seropositivity: a cohort study. | background: it is currently unclear whether betapapillomaviruses (betapv) play a role in the etiology of cutaneous squamous cell carcinoma (scc). we investigated the association between betapv antibodies and subsequent scc in a population-based cohort study. methods: serum samples were collected in 1992 and/or 1996 from 1,311 participants of the community-based nambour skin cancer study. these were tested for the presence of l1 antibodies against 21 different betapv types. histologically diagnos ... | 2011 | 21527580 |
| the relationship of knowledge, health value and health self-efficacy with men's intentions to receive the human papillomavirus (hpv) vaccine. | the aim of the present study was to determine whether it was possible to predict human papillomavirus (hpv) vaccination intentions an australian male sample. one hundred and twenty one males aged 18 to 26 (m = 22.3, sd = 2.06), completed an online survey assessing hpv-related knowledge, health beliefs and health self-efficacy. hpv knowledge and health self-efficacy were significant independent predictors of vaccine acceptance. a moderating effect was found between hpv knowledge and health self-e ... | 2011 | 21558104 |
| increasing cancer mortality among opioid-dependent persons in australia: a new public health challenge for a disadvantaged population. | objective: to examine cancer mortality in a population-based cohort of opioid-dependent persons. methods: new south wales opioid substitution therapy (ost) program registrants from 1985 to 2005 (n=43,789) were probabilistically linked to the national death index. crude and standardised mortality rates and standardised mortality ratios (smrs) were calculated. results: the crude cancer mortality rate increased from 4 to 65 deaths per 100,000 person-years (p trend <0.001). overall, ost registrants ... | 2011 | 21627721 |
| early effect of the hpv vaccination programme on cervical abnormalities in victoria, australia: an ecological study. | australia introduced a human papillomavirus (hpv) vaccination programme with the quadrivalent hpv vaccine for all women aged 12-26 years between 2007 and 2009. we analysed trends in cervical abnormalities in women in victoria, australia, before and after introduction of the vaccination programme. | 2011 | 21684381 |
| catching up with the catch-up: hpv vaccination coverage data for australian women aged 18-26 years from the national hpv vaccination program register. | this report describes human papillomavirus (hpv) vaccine coverage data for australian women 18-26 years of age, as notified to the national human papillomavirus vaccination program register. a cross-sectional analysis was conducted of notifications to the register of hpv vaccine doses delivered as part of the national hpv vaccination program, which provided free catch-up vaccination to women 18-26 years of age across australia between 2007 and 2009. hpv vaccination coverage estimates were calcul ... | 2011 | 22010515 |
| The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. | Background Australia provided free quadrivalent human papillomavirus vaccines to 12-18-year-old girls and women aged =26 years from mid-2007 until the end of 2009. After this time, only girls aged 12-13 years had access to free vaccines. Methods Before and after the study, of the proportion of new patients attending Melbourne Sexual Health Centre from mid-2004 to mid-2011, diagnosed with genital warts (GW) by risk group. Results From July 2004 to June 2011, 52?454 new patients were seen at Mel ... | 2011 | 21970896 |
| Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. | BACKGROUND: We evaluated the efficacy of the human papillomavirus HPV-16/18 AS04-adjuvanted vaccine against non-vaccine oncogenic HPV types in the end-of-study analysis after 4 years of follow-up in PATRICIA (PApilloma TRIal against Cancer In young Adults). METHODS: Healthy women aged 15-25 years with no more than six lifetime sexual partners were included in PATRICIA irrespective of their baseline HPV DNA status, HPV-16 or HPV-18 serostatus, or cytology. Women were randomly assigned (1:1) to HP ... | 2011 | 22075170 |
| will vaccinated women attend cervical screening? a population based survey of human papillomavirus vaccination and cervical screening among young women in victoria, australia. | objectives: to assess human papillomavirus (hpv) vaccination coverage and attitudes to vaccination and pap screening in young women. design: population-based telephone survey. setting: victoria, australia. participants: 234 women resident in victoria aged 18-28 years in may 2009. main outcome measures: self-reported hpv vaccination uptake, reasons for non-receipt or failure to complete vaccination, knowledge and attitudes about hpv vaccination and pap screening, and cervical screening intentions ... | 2011 | 22204834 |
| Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. | BACKGROUND: Cervical intraepithelial neoplasia grade 2 or greater (CIN2+) is the surrogate endpoint used in licensure trials of human papillomavirus (HPV) vaccines. Vaccine efficacy against CIN3+, the immediate precursor to invasive cervical cancer, is more difficult to measure because of its lower incidence, but provides the most stringent evidence of potential cancer prevention. We report vaccine efficacy against CIN3+ and adenocarcinoma in situ (AIS) in the end-of-study analysis of PATRICIA ( ... | 2011 | 22075171 |
| Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program. | Indigenous women in Australia have a disproportionate burden of cervical cancer despite a national cervical screening program. Prior to introduction of a national human papilloma virus (HPV) vaccination program, we determined HPV genotype prevalence by Indigenous status and residence in remote areas. | 2011 | 21910918 |
| cervical cancer in the human papillomavirus vaccination era. | to evaluate the potential changes in the epidemiology of cervical cancer based on recently emerged information from mass vaccination programs beyond clinical trials. | 2011 | 22123221 |
| NSW annual immunisation coverage report, 2010. | This annual report, the second in the series, documents trends in immunisation coverage in NSW for children, adolescents and the elderly, to the end of 2010. Methods: Data from the Australian Childhood Immunisation Register, the NSW School Immunisation Program and the NSW Population Health Survey were used to calculate various measures of population coverage, coverage for Aboriginal children and vaccination timeliness for all children. Results: Over 90% coverage has been reached for children at ... | 2011 | 22060056 |
| the performance of anal cytology as a screening test for anal hsils in homosexual men. | studies regarding the performance of anal cytology in which both the screening test (cytology) and the diagnostic test (high-resolution anoscopy [hra]) are performed in all members of a screening population are rare. the authors evaluated the performance of liquid-based anal cytology in a cohort of homosexual men in sydney, new south wales, australia. | 2016 | 26915346 |
| trends in incidence and survival for anal cancer in new south wales, australia, 1972-2009. | little is known about the incidence and survival of anal cancer in new south wales (nsw), australia, as anal cancer cases are often grouped together with other colorectal cancers in descriptive epidemiological analyses. | 2015 | 26651444 |
| immunisation coverage, 2012. | this, the 6th annual immunisation coverage report, documents trends during 2012 for a range of standard measures derived from australian childhood immunisation register (acir) data, and national human papillomavirus (hpv) vaccination program register data. these include coverage at standard age milestones and for individual vaccines included on the national immunisation program (nip) and coverage in adolescents and adults. the proportion of australian children 'fully vaccinated' at 12, 24 and 60 ... | 2014 | 25391407 |
| immunisation coverage annual report, 2011. | this, the 5th annual immunisation coverage report, documents trends during 2011 for a range of standard measures derived from australian childhood immunisation register data, and national human papillomavirus (hpv) vaccination program register data. the proportion of children 'fully vaccinated' at 12, 24 and 60 months of age was 91.4%, 92.2% and 89.5% respectively. although pneumococcal vaccine had similar coverage at 12 months to other vaccines, coverage was lower for rotavirus at 12 months (83 ... | 2013 | 24882234 |